Synaptogenix SNPX Stock
Synaptogenix Price Chart
Synaptogenix SNPX Financial and Trading Overview
| Synaptogenix stock price | 2.39 USD |
| Previous Close | 0.9 USD |
| Open | 0.91 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 3100 |
| Day's Range | 0.89 - 0.94 USD |
| 52 Week Range | 0.7 - 8.75 USD |
| Volume | 22.04K USD |
| Avg. Volume | 52.21K USD |
| Market Cap | 6.89M USD |
| Beta (5Y Monthly) | 1.613057 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.99 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14 USD |
SNPX Valuation Measures
| Enterprise Value | -29156746 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.57060975 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.21890058 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 1.849 |
Trading Information
Synaptogenix Stock Price History
| Beta (5Y Monthly) | 1.613057 |
| 52-Week Change | -81.64% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.75 USD |
| 52 Week Low | 0.7 USD |
| 50-Day Moving Average | 0.86 USD |
| 200-Day Moving Average | 3.19 USD |
SNPX Share Statistics
| Avg. Volume (3 month) | 52.21K USD |
| Avg. Daily Volume (10-Days) | 35.15K USD |
| Shares Outstanding | 7.36M |
| Float | 7.13M |
| Short Ratio | 0.67 |
| % Held by Insiders | 10.17% |
| % Held by Institutions | 6.06% |
| Shares Short | 36.41K |
| Short % of Float | 0.50% |
| Short % of Shares Outstanding | 0.48% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.62% |
| Return on Equity (ttm) | -12.69% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -15768320 USD |
| Net Income Avi to Common (ttm) | -4389783 USD |
| Diluted EPS (ttm) | -0.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.78M USD |
| Total Cash Per Share (mrq) | 4.86 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 28.592 |
| Book Value Per Share (mrq) | 4.275 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9421651 USD |
| Levered Free Cash Flow (ttm) | -4758545 USD |
Profile of Synaptogenix
| Country | United States |
| State | NY |
| City | New York |
| Address | 1185 Avenue of the Americas |
| ZIP | 10036 |
| Phone | 973 242 0005 |
| Website | https://www.synaptogen.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.
Q&A For Synaptogenix Stock
What is a current SNPX stock price?
Synaptogenix SNPX stock price today per share is 2.39 USD.
How to purchase Synaptogenix stock?
You can buy SNPX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Synaptogenix?
The stock symbol or ticker of Synaptogenix is SNPX.
Which industry does the Synaptogenix company belong to?
The Synaptogenix industry is Biotechnology.
How many shares does Synaptogenix have in circulation?
The max supply of Synaptogenix shares is 1.39M.
What is Synaptogenix Price to Earnings Ratio (PE Ratio)?
Synaptogenix PE Ratio is now.
What was Synaptogenix earnings per share over the trailing 12 months (TTM)?
Synaptogenix EPS is -10.99 USD over the trailing 12 months.
Which sector does the Synaptogenix company belong to?
The Synaptogenix sector is Healthcare.
Synaptogenix SNPX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17146.39 USD — |
-1.36
|
6.49B USD — | 17133.29 USD — | 17467.35 USD — | — - | 6.49B USD — |
| NASDAQ HealthCare IXHC | 924.57 USD — |
+0.11
|
— — | 923.44 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}